TABLE 3

Rate of Vaccine Tolerance in the Skin-Test Group (n = 56) Compared With the Non–Skin-Test Group (n = 115)

Outcome VariableSkin-Test GroupNon–Skin-Test GroupRate Ratio (95% CI)a
n% (Exact 95% CI)n% (Exact 95% CI)
No localized or systemic reaction4478.6 (65.6–88.4)9179.1 (70.6–86.2)1.12 (0.99–1.25)
No systemic reaction5394.6 (85.1–98.9)11196.5 (91.3–99.0)1.01 (0.97–1.06)
  • a Ratio with propensity score adjustment.